Elly and Lorna sit down with Ben Pask from Rare: Monitor, whose platform tracks over 100,000 healthcare providers. Their latest report reveals a sharp 5% drop in botulinum providers—largely unregulated ones—driven by stricter regulations. Ben’s data exposes a market pivoting toward professionalism, yet contending with consumer scepticism and concerns over unnatural outcomes.

Together, we dive into why 87% of providers cluster in affluent urban centres, why patients are spending more but visiting less, and the growing demand for holistic treatments like skin boosters and longevity therapies.

Find out more about Rare: Monitor.

Throughout April and May 2025, Rare: are publishing a series of reports on the UK injectable market across Dermal Fillers, Polynucleotides, Botulinum Toxin and Skin Boosters. All of which can be downloaded at rare.consulting. Rare Monitor tracks the activities of over 100,000 UK health beauty and wellness providers. Pharmaceutical and medical device manufacturers can improve their private market conversion rates at raremonitor.com.

Learn more about AestheticSource at: aestheticsource.com.

Follow Lorna on LinkedIn.

Follow Elly on Instagram.

This episode was bought to you by AestheticSource, researched, planned, and created by Elly Makinson and produced by Urban Podcasts.